Space.com on MSN

Lower-cost space missions like NASA's ESCAPADE are starting to deliver exciting science – but at a price in risk and trade‑offs

This low-cost mission is still only getting started, and it's taking bigger risks than typical big-ticket NASA missions.
Nasdaq

Exact Sciences price target raised to $70 from $60 at Evercore ISI

Evercore ISI analyst Vijay Kumar raised the firm’s price target on Exact Sciences (EXAS) to $70 from $60 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for MedTech, Life ...
Nasdaq

180 Life Sciences prices $2.9M registered direct offering at $2.41 per share

180 Life Sciences (ATNF) announced that it has entered into a securities purchase agreement with several institutional investors to sell 1,200,000 shares of common stock in a registered direct ...
Hosted on MSN

Wave Life Sciences price target raised to $30 from $22 at HC Wainwright

H.C. Wainwright analyst Andrew Fein raised the firm’s price target on Wave Life Sciences (WVE) to $30 from $22 and keeps a Buy rating on the shares. The firm says its key opinion leader validation and ...
Business Insider

Exact Sciences price target lowered to $65 from $82 at BTIG

BTIG analyst Mark Massaro lowered the firm’s price target on Exact Sciences (EXAS) to $65 from $82 and keeps a Buy rating on the shares. The company delivered a Q3 revenue miss and large guide-down, ...
Yahoo Finance

Sight Sciences price target raised to $12 from $7 at UBS

UBS raised the firm’s price target on Sight Sciences (SGHT) to $12 from $7 and keeps a Buy rating on the shares. Medicare Administrative Contractors Novitas and First Coast Service Option established ...
Seeking Alpha

Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

CAMBRIDGE, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human ...
Business Insider

Exact Sciences price target raised to $95 from $75 at Canaccord

Canaccord raised the firm’s price target on Exact Sciences (EXAS) to $95 from $75 and keeps a Buy rating on the shares. The firm said they are bullish heading into earnings and 2025 as recent weakness ...
NJBIZ

Integra LifeSciences Prices Offering at 25.50

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.
Seeking Alpha

Kodiak Sciences prices upsized $160M stock offering at $23.00 per share

Kodiak Sciences (KOD) has priced an expanded public offering of approximately 6.96 million shares at $23.00 each. The company expects to raise roughly $160 million in gross proceeds. Kodiak Sciences ...
EurekAlert!

Why the effectiveness of ETSs on green innovation differs? The perspective from price stabilization mechanisms

Price stabilization mechanisms (PSMs), one of a set of key policy elements aiming at supporting increasing and stable carbon prices, may affect the performance of emissions trading systems (ETS) in ...